ADYX
ADYNXX INC
stock OTC

alliqua biomedical, inc. (nasdaq:alqa) ("alliqua") is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds. alliqua is building this portfolio through its proprietary hydrogel technology platform, targeted acquisitions, and through licensing and distribution agreements with strategic partners that include sorbion gmbh & co. kg and celgene cellular therapeutics, a subsidiary of celgene corporation. alliqua's contract manufacturing business unit provides custom hydrogels to the oem market. the company is headquartered in langhorne, pa.